Jasper Therapeutics, Inc.
JSPR
Price:
$22.86
Market Cap:
$345.31M
Jasper Therapeutics, Inc., a clinical-stage biotechnology company, develops therapeutic agents for hematopoietic stem cell transplantation and gene therapies. It focuses on the development and commercialization of conditioning agents and stem cell engineering to allow expanded use of stem cell transplantation and ex vivo gene therapy, a technique in which genetic manipulation of cells is performed outside the body prior to transplantation. The company's lead product candidate is JSP191, which is in clinical development as a conditioning antibody that clears hematopoietic stem cells from bone marrow in patients prior to undergoing allogeneic stem cell therapy or stem cell gene therapy. It is ...[Read more]
Industry
Biotechnology
IPO Date
2020-01-10
Stock Exchange
NASDAQ
Ticker
JSPR
The ROE as of September 2024 (TTM) for Jasper Therapeutics, Inc. (JSPR) is -64.68%
According to Jasper Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -64.68%. This represents a change of 289.43% compared to the average of -16.61% of the last 4 quarters.
Jasper Therapeutics, Inc. (JSPR) Historical ROE (quarterly & annually)
How has JSPR ROE performed in the past?
The mean historical ROE of Jasper Therapeutics, Inc. over the last ten years is -23.47%. The current -64.68% ROE has changed 175.62% with respect to the historical average. Over the past ten years (40 quarters), JSPR's ROE was at its highest in in the December 2020 quarter at 28.43%. The ROE was at its lowest in in the September 2020 quarter at -216.50%.
Average
-23.47%
Median
-34.50%
Minimum
-82.18%
Maximum
90.15%
Jasper Therapeutics, Inc. (JSPR) ROE by Quarter and Year
Discovering the peaks and valleys of Jasper Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 94.69%
Maximum Annual ROE = 90.15%
Minimum Annual Increase = -481.45%
Minimum Annual ROE = -82.18%
| Year | ROE | Change |
|---|---|---|
| 2023 | -82.18% | 22.35% |
| 2022 | -67.17% | 94.69% |
| 2021 | -34.50% | -138.27% |
| 2020 | 90.15% | -481.45% |
Jasper Therapeutics, Inc. (JSPR) Average ROE
How has JSPR ROE performed in the past?
The current ROE of Jasper Therapeutics, Inc. (JSPR) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages
3-year avg
-61.28%
5-year avg
-23.47%
10-year avg
-23.47%
Jasper Therapeutics, Inc. (JSPR) ROE vs. Peers
How is JSPR’s ROE compared to its peers?
Jasper Therapeutics, Inc.’s ROE is greater than Lyra Therapeutics, Inc. (-143.74%), greater than Equillium, Inc. (-36.88%), greater than HOOKIPA Pharma Inc. (-51.77%), greater than LianBio (-38.06%), greater than Acumen Pharmaceuticals, Inc. (-24.63%), less than Galera Therapeutics, Inc. (21.95%), greater than Inozyme Pharma, Inc. (-68.93%), greater than Eledon Pharmaceuticals, Inc. (-124.74%), greater than Icosavax, Inc. (-41.24%), greater than Edgewise Therapeutics, Inc. (-28.01%), greater than Ikena Oncology, Inc. (-42.81%), greater than Design Therapeutics, Inc. (-18.48%), greater than Xilio Therapeutics, Inc. (-176.51%), greater than Eliem Therapeutics, Inc. (-47.03%), less than POINT Biopharma Global Inc. (0%), less than ORIC Pharmaceuticals, Inc. (21.10%), greater than Inhibrx, Inc. (-40.19%), less than ESSA Pharma Inc. (1.62%), greater than null (-20.17%),
| Company | ROE | Market cap |
|---|---|---|
| -143.74% | $18.31M | |
| -36.88% | $30.15M | |
| -51.77% | $162.87M | |
| -38.06% | $34.47M | |
| -24.63% | $152.00M | |
| 21.95% | $3.76M | |
| -68.93% | $376.09M | |
| -124.74% | $104.29M | |
| -41.24% | $769.04M | |
| -28.01% | $1.59B | |
| -42.81% | $82.04M | |
| -18.48% | $315.66M | |
| -176.51% | $36.86M | |
| -47.03% | $552.58M | |
| 0% | $1.33B | |
| 21.10% | $704.72M | |
| -40.19% | $253.33M | |
| 1.62% | $314.13M | |
| -20.17% | $0 |
Build a custom stock screener for Jasper Therapeutics, Inc. (JSPR) and other stocks
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Jasper Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
Jasper Therapeutics, Inc. (JSPR) and other stocks custom spreadsheet templates
The easiest way to analyze a company like Jasper Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
Frequently asked questions❓
What is the ROE?
How can you use the ROE?
What is Jasper Therapeutics, Inc.'s ROE?
How is the ROE calculated for Jasper Therapeutics, Inc. (JSPR)?
What is the highest ROE for Jasper Therapeutics, Inc. (JSPR)?
What is the 3-year average ROE for Jasper Therapeutics, Inc. (JSPR)?
What is the 5-year average ROE for Jasper Therapeutics, Inc. (JSPR)?
How does the current ROE for Jasper Therapeutics, Inc. (JSPR) compare to its historical average?